Microbix Biosystems Inc. · Toronto, ON Canada ·(Toronto: MBX)
Company Description
View Microbix Biosystems Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window Microbix makes biotherapeutic drugs, vaccines, and infectious disease diagnostics for multinational manufacturers. The company's pipeline includes leading generic drug candidate ThromboClear for the treatment of coronary artery thrombosis and the FDA-approved drug urokinase, used to treat pulmonary embolism. Microbix has also submitted patents for its Sperm Sexing Technology, which enables livestock producers to predetermine offspring gender prior to conception. In 2008 Microbix entered into an agreement with China to build one of the world's largest influenza manufacturing plants to produce flu vaccines. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Microbix Biosystems Inc. Financials
| Company Type | Public - Toronto: MBX Single Location |
| Fiscal Year-End | September |
| 2008 Sales (mil.) | $4.8 |
| Employees | 33 |
Microbix Biosystems Inc. Executives
6 executives listed for Microbix Biosystems Inc.'s Toronto, ON location.
| Title | Name & Bio | Contact |
| Chairman and CEO | William Gastle | Network |
| President | Philip Casselli | Network |
| CFO | James Long | Network |
Competition
Top Microbix Biosystems Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!